1-3 of 3
Blanca Sánchez
Close
Sort by
Journal Articles

Rituximab, Bendamustine, Mitoxantrone, Dexamethasone (R-BMD) in Patients with Follicular Lymphoma in Relapse or Refractory to First-Line Treatment with Immunochemotherapy. R-BMD Geltamo 08 Trial

Francisco Javier Peñalver, José Antonio Márquez, Soledad Durán, Pilar Giraldo, Carlos Montalban, María José Ramírez, Juan Manuel Sancho, María José Terol, MD, PhD, Francisco Javier Capote, Antonio Gutiérrez, Blanca Sánchez, Miguel Canales, María Dolores Caballero
Journal: Blood
Blood (2012) 120 (21): 1639.
https://doi.org/10.1182/blood.V120.21.1639.1639
Published: 2012
Journal Articles

Modified-CHOP with Reduced Dose of Non-Pegylated Liposomal Doxorubicin ± Rituximab in First Line Treatment for Elderly Patients with Aggressive Lymphoma Non Suitables for Standard Chemotherapy.

Eva Gimeno, Blanca Sánchez, Alberto Alvarez, Carme Pedro, Eugenia Abella, Miquel Gomez, Silvia Saumell, Josep Comin, Carles Besses, Antonio Salar
Journal: Blood
Blood (2009) 114 (22): 4752.
https://doi.org/10.1182/blood.V114.22.4752.4752
Published: 2009
Journal Articles

Cisplatin-Based Protocols as Salvage Therapy for Relapsed or Refractory Hodgkin’s Lymphoma Patients.

Iván Alvarez, MD, Anna Sureda, MD, Reyes Arranz, MD, Raúl Córdoba, MD, Blanca Xicoy, MD, Blanca Sánchez, MD, María Teresa Bernal, MD, María Isabel G. Roncero, MD, Edelmira Martí, MD, Alberto Pliego, MD, Pascual Fernández-Abellán, MD, Josep María Ribera, MD, Jose María Fernández-Rañada, MD, Jorge Sierra, MD
Journal: Blood
Blood (2005) 106 (11): 2676.
https://doi.org/10.1182/blood.V106.11.2676.2676
Published: 2005